Expression of type I insulin-like growth factor receptor (IGF1R) in tamoxifen-resistant cells: Implications for cotargeting of IGF1R and estrogen receptor (ER) in breast cancer.
Dedra H. Fagan
No relevant relationships to disclose
Ryan R. Uselman
No relevant relationships to disclose
Deepali Sachdev
No relevant relationships to disclose
Douglas Yee
Research Funding - Merck Sharp & Dohme